Virtus ETF Advisers LLC Annovis Bio, Inc. Transaction History

Virtus ETF Advisers LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$17.58 - $37.67 $41,963 - $89,918	-2,387 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$30.95 - $120.97 $4,054 - $15,847	-131 Reduced 5.2%	2,387 $76,000
Q2 2021 Aug 10, 2021	BUY	$21.55 - $96.1 $54,262 - $241,979	2,518 New	2,518 $215,000

1.17M

229K

934K

Ticker ANVS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,163,920
Market Cap $35.7M
Description
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.